Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Influenza vaccination reveals and partly reverses sex dimorphic immune imprints associated with prior mild COVID-19

View ORCID ProfileRachel Sparks, View ORCID ProfileWilliam W. Lau, Can Liu, Kyu Lee Han, Kiera L. Vrindten, Guangping Sun, Milann Cox, Sarah F. Andrews, Neha Bansal, Laura E. Failla, Jody Manischewitz, Gabrielle Grubbs, Lisa R. King, Galina Koroleva, Stephanie Leimenstoll, LaQuita Snow, OP11 Clinical Staff, Jinguo Chen, Juanjie Tang, Amrita Mukherjee, Brian A. Sellers, Richard Apps, Adrian B. McDermott, Andrew J. Martins, Evan M. Bloch, Hana Golding, Surender Khurana, View ORCID ProfileJohn S. Tsang
doi: https://doi.org/10.1101/2022.02.17.22271138
Rachel Sparks
1Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rachel Sparks
William W. Lau
1Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for William W. Lau
Can Liu
1Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA
2Graduate Program in Biological Sciences, University of Maryland, College Park, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kyu Lee Han
3NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kiera L. Vrindten
1Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guangping Sun
1Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA
4Division of Intramural Research, NIAID, NIH, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Milann Cox
1Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah F. Andrews
5Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neha Bansal
1Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura E. Failla
1Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jody Manischewitz
6Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabrielle Grubbs
6Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa R. King
6Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Galina Koroleva
3NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephanie Leimenstoll
7Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LaQuita Snow
7Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
8NIH Clinical Center, NIH, Bethesda, MD, USA
Jinguo Chen
3NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juanjie Tang
6Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amrita Mukherjee
3NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian A. Sellers
3NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Apps
3NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrian B. McDermott
5Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew J. Martins
1Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evan M. Bloch
9Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hana Golding
6Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Surender Khurana
6Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John S. Tsang
1Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA
3NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John S. Tsang
  • For correspondence: john.tsang{at}nih.gov
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Viral infections can have profound and durable functional impacts on the immune system. There is an urgent need to characterize the long-term immune effects of SARS-CoV-2 infection given the persistence of symptoms in some individuals and the continued threat of novel variants including the recent rapid acceleration in infections. As the majority of COVID-19 patients experienced mild disease, here we use systems immunology approaches to comparatively assess the post-infection immune status (mean: 151 [5th – 95th percentile: 58 – 235] days after diagnosis) and subsequent innate and adaptive responses to seasonal influenza vaccination (as an “immune challenge”) in 33 previously healthy individuals after recovery from mild, non-hospitalized COVID-19, as compared to 40 age- and sex-matched healthy controls with no history of COVID-19. Sex-specific, temporally stable shifts in signatures of metabolism, T-cell activation, and innate immune/inflammatory processes suggest that mild COVID-19 can establish new post-infection immunological set-points. COVID-19-recovered males had an increase in CD71hi B-cells (including influenza-specific subsets) before vaccination and more robust innate, influenza-specific plasmablast, and antibody responses after vaccination compared to healthy males. Intriguingly, by day 1 post-vaccination in COVID-19-recovered subjects, the expression of numerous innate defense/immune receptor genes (e.g., Toll-like receptors) in monocytes increased and moved away from their post-COVID-19 repressed state toward the pre-vaccination baseline of healthy controls, and these changes tended to persist to day 28 in females, hinting that the acute inflammatory responses induced by vaccination could partly reset the immune states established by prior mild COVID-19. Our study reveals sex-dimorphic immune imprints and in vivo functional impacts of mild COVID-19 in humans, suggesting that prior COVID-19 could change future responses to vaccination and in turn, vaccines could help reset the immune system after COVID-19, both in an antigen-agnostic manner.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Protocols

https://clinicaltrials.gov/ct2/show/NCT04025580

Funding Statement

This research was supported by the Intramural Research Programs of the NIAID and the Intramural Programs of the NIH Institutes supporting the NIH Center for Human Immunology.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Study participants were enrolled on National Institutes of Health (NIH) protocol 19-I-0126 (Systems analyses of the immune response to the seasonal influenza vaccine; NCT04025580), approved by the NIH Institutional Review Board. Informed consent was obtained from all participants and all relevant ethical regulations have been complied.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Raw and processed data from the whole blood bulk RNAseq are available from the NCBI Gene Expression Omnibus, accession number GEO: GSE194378 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE194378; will be released to public at the time of publication). Additional datasets, including clinical, proteomics, flow cytometry, CITE-seq, and influenza antibody measurements, are available at: https://doi.org/10.5281/zenodo.5935845 (will be released to public at time of publication). The influenza infection dataset we utilized was downloaded directly from GEO: GSE68310 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE68310).

https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE194378

https://doi.org/10.5281/zenodo.5935845

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Back to top
PreviousNext
Posted February 22, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Influenza vaccination reveals and partly reverses sex dimorphic immune imprints associated with prior mild COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Influenza vaccination reveals and partly reverses sex dimorphic immune imprints associated with prior mild COVID-19
Rachel Sparks, William W. Lau, Can Liu, Kyu Lee Han, Kiera L. Vrindten, Guangping Sun, Milann Cox, Sarah F. Andrews, Neha Bansal, Laura E. Failla, Jody Manischewitz, Gabrielle Grubbs, Lisa R. King, Galina Koroleva, Stephanie Leimenstoll, LaQuita Snow, OP11 Clinical Staff, Jinguo Chen, Juanjie Tang, Amrita Mukherjee, Brian A. Sellers, Richard Apps, Adrian B. McDermott, Andrew J. Martins, Evan M. Bloch, Hana Golding, Surender Khurana, John S. Tsang
medRxiv 2022.02.17.22271138; doi: https://doi.org/10.1101/2022.02.17.22271138
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Influenza vaccination reveals and partly reverses sex dimorphic immune imprints associated with prior mild COVID-19
Rachel Sparks, William W. Lau, Can Liu, Kyu Lee Han, Kiera L. Vrindten, Guangping Sun, Milann Cox, Sarah F. Andrews, Neha Bansal, Laura E. Failla, Jody Manischewitz, Gabrielle Grubbs, Lisa R. King, Galina Koroleva, Stephanie Leimenstoll, LaQuita Snow, OP11 Clinical Staff, Jinguo Chen, Juanjie Tang, Amrita Mukherjee, Brian A. Sellers, Richard Apps, Adrian B. McDermott, Andrew J. Martins, Evan M. Bloch, Hana Golding, Surender Khurana, John S. Tsang
medRxiv 2022.02.17.22271138; doi: https://doi.org/10.1101/2022.02.17.22271138

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (427)
  • Allergy and Immunology (753)
  • Anesthesia (220)
  • Cardiovascular Medicine (3281)
  • Dentistry and Oral Medicine (362)
  • Dermatology (274)
  • Emergency Medicine (478)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1164)
  • Epidemiology (13338)
  • Forensic Medicine (19)
  • Gastroenterology (896)
  • Genetic and Genomic Medicine (5128)
  • Geriatric Medicine (479)
  • Health Economics (781)
  • Health Informatics (3252)
  • Health Policy (1137)
  • Health Systems and Quality Improvement (1189)
  • Hematology (427)
  • HIV/AIDS (1012)
  • Infectious Diseases (except HIV/AIDS) (14611)
  • Intensive Care and Critical Care Medicine (908)
  • Medical Education (475)
  • Medical Ethics (126)
  • Nephrology (521)
  • Neurology (4899)
  • Nursing (261)
  • Nutrition (725)
  • Obstetrics and Gynecology (879)
  • Occupational and Environmental Health (795)
  • Oncology (2515)
  • Ophthalmology (722)
  • Orthopedics (280)
  • Otolaryngology (346)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (537)
  • Pediatrics (1297)
  • Pharmacology and Therapeutics (548)
  • Primary Care Research (554)
  • Psychiatry and Clinical Psychology (4190)
  • Public and Global Health (7482)
  • Radiology and Imaging (1701)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (979)
  • Rheumatology (478)
  • Sexual and Reproductive Health (495)
  • Sports Medicine (424)
  • Surgery (545)
  • Toxicology (71)
  • Transplantation (235)
  • Urology (203)